Clinical trial NCT07009860 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-08-31 → 2027-09-30 3. primary completion date: 2027-03-31 → 2027-09-30 4. enrollment: 100 → 121 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07655505 updates: 1. status: NOT_YET_RECRUITING → ENROLLING_BY_INVITATION 2. start date: 2026-06-01 → 2026-07-06
Clinical trial NCT05995340 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-01 → 2026-07-14 3. primary completion date: 2026-08-01 → 2026-07-14
Clinical trial NCT02687906 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-12-01 → 2026-07-15 3. primary completion date: 2026-12-01 → 2026-07-01
Clinical trial NCT05004337: enrollment: 126 → 136 participants.
Clinical trial NCT06101329: primary completion date: 2026-07-01 → 2026-07-22.
Clinical trial NCT07218770 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2028-06-28 → 2026-07-21 3. primary completion date: 2028-06-28 → 2026-07-21 4. enrollment: 72 → 1 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05386472: completion date: 2025-05-12 → 2025-05-13.
Clinical trial NCT06616766: enrollment: 161 → 201 participants.
Share Buy Back - Daily Share Buy-Back Notice: Share Buy-Back - Daily Share Buy-Back